{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:51:29Z","timestamp":1791820289620,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00414-026-03876-0","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:32:18Z","timestamp":1784079138000},"page":"3809-3821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postmortem case series of \u03948- and \u03949-tetrahydrocannabinol in blood and urine"],"prefix":"10.1007","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8873-8993","authenticated-orcid":false,"given":"Munchelou M.","family":"Gomonit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-650X","authenticated-orcid":false,"given":"Marco","family":"Ballotari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-5379","authenticated-orcid":false,"given":"Michael T.","family":"Truver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6846-7677","authenticated-orcid":false,"given":"Jennifer L.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5799-1787","authenticated-orcid":false,"given":"Bruce A.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-7987","authenticated-orcid":false,"given":"Chris W.","family":"Chronister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"3876_CR1","unstructured":"Establishment of a Domestic Hemp Production Program. Federal Register (2021) https:\/\/www.federalregister.gov\/documents\/2021\/01\/19\/2021-00967\/establishment-of-a-domestic-hemp-production-program (accessed December 16, 2025)"},{"key":"3876_CR2","unstructured":"Agriculture Improvement Act of 2018, Pub L No. 115-334, 132 Stat 4490 (2018). https:\/\/www.govinfo.gov\/content\/pkg\/PLAW-115publ334\/pdf\/PLAW-115publ334.pdf"},{"issue":"2","key":"3876_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/dta.3519","volume":"16","author":"I Ujv\u00e1ry","year":"2024","unstructured":"Ujv\u00e1ry I (2024) Hexahydrocannabinol and closely related semi-synthetic cannabinoids: a comprehensive review. Drug Test Anal 16(2):127\u201361. https:\/\/doi.org\/10.1002\/dta.3519","journal-title":"Drug Test Anal"},{"key":"3876_CR4","doi-asserted-by":"publisher","unstructured":"Geci M, Scialdone M, Tishler J (2023) The dark side of cannabidiol: the unanticipated social and clinical implications of synthetic \u03948-THC. Cannabis Cannabinoid Res 8(2):270\u2013282. https:\/\/doi.org\/10.1089\/can.2022.0126","DOI":"10.1089\/can.2022.0126"},{"issue":"15","key":"3876_CR5","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1111\/bph.15865","volume":"179","author":"M Tagen","year":"2022","unstructured":"Tagen M, Klumpers LE (2022) Review of delta-8-tetrahydrocannabinol (\u03948-THC): comparative pharmacology with \u03949-THC. Br J Pharmacol 179(15):3915\u201333. https:\/\/doi.org\/10.1111\/bph.15865","journal-title":"Br J Pharmacol"},{"key":"3876_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpba.2017.07.021","volume":"146","author":"B Patel","year":"2017","unstructured":"Patel B, Wene D, Fan Z (2017) Qualitative and quantitative measurement of cannabinoids in cannabis using modified HPLC\/DAD method. J Pharm Biomed Anal 146:15\u201323. https:\/\/doi.org\/10.1016\/j.jpba.2017.07.021","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"3876_CR7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/sj.bjp.0702469","volume":"126","author":"G Griffin","year":"1999","unstructured":"Griffin G, Wray EJ, Rorrer WK, Crocker PJ, Ryan WJ, Saha B et al (1999) An investigation into the structural determinants of cannabinoid receptor ligand efficacy. Br J Pharmacol 126(7):1575\u201384. https:\/\/doi.org\/10.1038\/sj.bjp.0702469","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3876_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3940(96)13233-X","volume":"220","author":"RA Hirst","year":"1996","unstructured":"Hirst RA, Almond SL, Lambert DG (1996) Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist. Neurosci Lett 220(2):101\u20134. https:\/\/doi.org\/10.1016\/S0304-3940(96)13233-X","journal-title":"Neurosci Lett"},{"issue":"1","key":"3876_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/can.2021.0124","volume":"8","author":"DJ Kruger","year":"2023","unstructured":"Kruger DJ, Kruger JS (2023) Consumer experiences with Delta-8-THC: medical use, pharmaceutical substitution, and comparisons with Delta-9-THC. Cannabis Cannabinoid Res 8(1):166\u201373. https:\/\/doi.org\/10.1089\/can.2021.0124","journal-title":"Cannabis Cannabinoid Res"},{"key":"3876_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1081\/TXR-120026915","volume":"22","author":"I Yamamoto","year":"2003","unstructured":"Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H (2003) Pharmacology and toxicology of major constituents of marijuana\u2014on the metabolic activation of cannabinoids and its mechanism. Toxin Rev 22:577\u201389. https:\/\/doi.org\/10.1081\/TXR-120026915","journal-title":"Toxin Rev"},{"key":"3876_CR11","doi-asserted-by":"publisher","unstructured":"Sim YE, Kim JW, Ko BJ, Kim JY, Cheong JC, Pyo J (2023) Determination of urinary metabolites of cannabidiol, \u03948-tetrahydrocannabinol, and \u03949-tetrahydrocannabinol by automated online \u00b5SPE\u2013LC\u2013MS\/MS method. J Chromatogr B 1214, 123568. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123568","DOI":"10.1016\/j.jchromb.2022.123568"},{"key":"3876_CR12","doi-asserted-by":"publisher","unstructured":"Leas EC, Harati RM, Satybaldiyeva N, Morales NE, Huffaker SL, Mejorado T et al (2023) Self-reported adverse events associated with \u22068-Tetrahydrocannabinol (Delta-8-THC) use. J Cannabis Res 5(1):15. https:\/\/doi.org\/10.1186\/s42238-023-00191-y","DOI":"10.1186\/s42238-023-00191-y"},{"issue":"6","key":"3876_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.16142","volume":"118","author":"CR LoParco","year":"2023","unstructured":"LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY (2023) Delta-8 tetrahydrocannabinol: a scoping review and commentary. Addiction 118(6):1011\u201328. https:\/\/doi.org\/10.1111\/add.16142","journal-title":"Addiction"},{"key":"3876_CR14","doi-asserted-by":"publisher","unstructured":"Kruger JS, Kruger DJ (2022) Delta-8-THC: Delta-9-THC\u2019s nicer younger sibling? J Cannabis Res 4:4. https:\/\/doi.org\/10.1186\/s42238-021-00115-8","DOI":"10.1186\/s42238-021-00115-8"},{"issue":"5","key":"3876_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jat\/bkaf023","volume":"49","author":"LS Muir","year":"2025","unstructured":"Muir LS, Doumit SE, Seither JZ, Knittel JL, Walterscheid JP, Karschner EL (2025) Comprehensive LC\u2013MS-MS analysis of THC isomers, analogs, homologs, and metabolites in blood and urine. J Anal Toxicol 49(5):322\u201331. https:\/\/doi.org\/10.1093\/jat\/bkaf023","journal-title":"J Anal Toxicol"},{"issue":"1","key":"3876_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkab029","volume":"46","author":"A Chan-Hosokawa","year":"2022","unstructured":"Chan-Hosokawa A, Nguyen L, Lattanzio N, Adams WR (2022) Emergence of Delta-8 tetrahydrocannabinol in DUID investigation casework: method development, validation and application. J Anal Toxicol 46(1):1\u20139. https:\/\/doi.org\/10.1093\/jat\/bkab029","journal-title":"J Anal Toxicol"},{"issue":"2","key":"3876_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/jat\/bkae091","volume":"49","author":"AL Patton","year":"2025","unstructured":"Patton AL, Muir L, Seither JZ, Walterscheid JP, Karschner EL (2025) LC\u2013MS\u2013MS confirmation of 11-nor-9-carboxy-tetrahydrocannabinol (\u03948, \u03949, \u039410) and hexahydrocannabinol metabolites in authentic urine specimens. J Anal Toxicol 49(2):96\u2013103. https:\/\/doi.org\/10.1093\/jat\/bkae091","journal-title":"J Anal Toxicol"},{"issue":"2\u20133","key":"3876_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0379-0738(01)00538-2","volume":"123","author":"C Giroud","year":"2001","unstructured":"Giroud C, M\u00e9n\u00e9trey A, Augsburger M et al (2001) Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci Int 123(2\u20133):159\u2013164. https:\/\/doi.org\/10.1016\/s0379-0738(01)00538-2","journal-title":"Forensic Sci Int"},{"issue":"7","key":"3876_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/anatox\/35.7.394","volume":"35","author":"NP Lemos","year":"2011","unstructured":"Lemos NP, Ingle EA (2011) Cannabinoids in postmortem toxicology. J Anal Toxicol 35(7):394\u2013401. https:\/\/doi.org\/10.1093\/anatox\/35.7.394","journal-title":"J Anal Toxicol"},{"issue":"6","key":"3876_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/jat\/bkx033","volume":"41","author":"SR Saenz","year":"2017","unstructured":"Saenz SR, Lewis RJ, Angier MK, Wagner JR (2017) Postmortem fluid and tissue concentrations of THC, 11-OH-THC and THC-COOH\u2020. J Anal Toxicol 41(6):508\u201316. https:\/\/doi.org\/10.1093\/jat\/bkx033","journal-title":"J Anal Toxicol"},{"key":"3876_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.forsciint.2011.06.028","volume":"212","author":"MG Holland","year":"2011","unstructured":"Holland MG, Schwope DM, Stoppacher R, Gillen SB, Huestis MA (2011) Postmortem redistribution of \u03949-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH). Forensic Sci Int 212:247\u201351. https:\/\/doi.org\/10.1016\/j.forsciint.2011.06.028","journal-title":"Forensic Sci Int"},{"issue":"9","key":"3876_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/jat\/bkz065","volume":"43","author":"AI Al-Asmari","year":"2019","unstructured":"Al-Asmari AI (2019) Method for postmortem quantification of \u03949-tetrahydrocannabinol and metabolites using LC\u2013MS\u2013MS. J Anal Toxicol 43(9):703\u201319. https:\/\/doi.org\/10.1093\/jat\/bkz065","journal-title":"J Anal Toxicol"},{"key":"3876_CR23","doi-asserted-by":"publisher","unstructured":"Hoffman MA, Trochta A, Gary RD, Fitzgerald RL, McIntyre IM (2020) An evaluation of postmortem concentrations of \u03949-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-\u03949-tetrahydrocannabinol (THCCOOH). Forensic Sci Int 315:110414. https:\/\/doi.org\/10.1016\/j.forsciint.2020.110414","DOI":"10.1016\/j.forsciint.2020.110414"},{"issue":"1","key":"3876_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/jat\/29.1.58","volume":"29","author":"D-L Lin","year":"2005","unstructured":"Lin D-L, Lin R (2005) Distribution of 11-Nor-9-Carboxy-\u03949-tetrahydrocannabinol in Traffic Fatality Cases. J Anal Toxicol 29(1):58\u201361","journal-title":"J Anal Toxicol"},{"issue":"8","key":"3876_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jat\/bkv095","volume":"39","author":"NP Lemos","year":"2015","unstructured":"Lemos NP, San Nicolas AC, Volk JA, Ingle EA, Williams CM (2015) Driving under the influence of marijuana versus driving and dying under the influence of marijuana: a comparison of blood concentrations of \u0394-tetrahydrocannabinol, 11-hydroxy-\u0394-tetrahydrocannabinol, 11-nor-9-carboxy-\u0394-tetrahydrocannabinol and other cannabinoids in arrested drivers versus deceased drivers. J Anal Toxicol 39(8):588\u2013601. https:\/\/doi.org\/10.1093\/jat\/bkv095","journal-title":"J Anal Toxicol"},{"issue":"8","key":"3876_CR26","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00216-025-05738-x","volume":"417","author":"M Ballotari","year":"2025","unstructured":"Ballotari M, Truver MT, Sojin NA, Agliano LA, Parimoo R, Hoyer JL et al (2025) Quantitative analysis of \u03948- and \u03949-tetrahydrocannabinol metabolites and isomers: a rapid assay in urine by LC-MS\/MS. Anal Bioanal Chem 417(8):1507\u201318. https:\/\/doi.org\/10.1007\/s00216-025-05738-x","journal-title":"Anal Bioanal Chem"},{"key":"3876_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jat\/bkad023","volume":"47","author":"MM Crosby","year":"2023","unstructured":"Crosby MM, Truver MT, Chronister CW, Hoyer JL, Kinsey AM, Brogan SC et al (2023) Identification of 11-nor-\u22068-tetrahydrocannabinol-9-carboxylic acid in postmortem urine. J Anal Toxicol 47:481\u20137. https:\/\/doi.org\/10.1093\/jat\/bkad023","journal-title":"J Anal Toxicol"},{"key":"3876_CR28","unstructured":"Brown GJ (2025) Blood Cannabinoid Findings in Human Performance and Postmortem Casework from 2024\u20132025: Implications in Forensic Toxicology Laboratories. Oral presentation at the Society of Forensic Toxicologists Annual Meeting, Portland, OR, USA, 27\u201331 October 2025."},{"key":"3876_CR29","doi-asserted-by":"publisher","first-page":"112676","DOI":"10.1016\/j.drugalcdep.2025.112676","volume":"272","author":"CA Zamarripa","year":"2025","unstructured":"Zamarripa CA, Spindle TR, Schriefer D, Cone EJ, Winecker RE, Flegel R et al (2025) A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults. Drug Alcohol Depend 272:112676. https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112676","journal-title":"Drug Alcohol Depend"},{"key":"3876_CR30","doi-asserted-by":"publisher","first-page":"112684","DOI":"10.1016\/j.drugalcdep.2025.112684","volume":"272","author":"TR Spindle","year":"2025","unstructured":"Spindle TR, Zamarripa CA, Schriefer D, Cone EJ, Winecker R, Flegel R et al (2025) A within-subject cross-over trial comparing the acute effects of vaporized delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults. Drug Alcohol Depend 272:112684. https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112684","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3876_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PAF.0000000000000887","volume":"45","author":"SL Kacinko","year":"2024","unstructured":"Kacinko SL, Isenschmid DS, Logan BK (2024) Are postmortem cannabinoid concentrations forensically reliable? Am J Forensic Med Pathol 45(1):92. https:\/\/doi.org\/10.1097\/PAF.0000000000000887","journal-title":"Am J Forensic Med Pathol"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-026-03876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00414-026-03876-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-026-03876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:41:55Z","timestamp":1791819715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00414-026-03876-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3876"],"URL":"https:\/\/doi.org\/10.1007\/s00414-026-03876-0","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}